1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 573 F.Supp.3d
  5. 573 F.Supp.3d 459 (2021)
 

IN RE RANBAXY GENERIC DRUG APP. ANTITRUST LIT.

MDL No. 19-md-02878-NMG.

573 F.Supp.3d 459 (2021)

IN RE: RANBAXY GENERIC DRUG APPLICATION ANTITRUST LITIGATION, This Document Relates to: Cross-Motions for Summary Judgment.

United States District Court, D. Massachusetts.

Signed November 22, 2021.

MEMORANDUM & ORDER

This multi-district litigation involves five actions which were centralized in this Court and divided into two classes against Ranbaxy Inc. and Sun Pharmaceutical Industries Limited (collectively, "Ranbaxy" or "defendants...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases